CKD (6407) investor relations material

Executive summary

• Net sales for 1Q FY2027 reached ¥49,108 million, up 35.5% year-over-year, with operating income at ¥8,032 million, up 112.9% year-over-year, driven by strong demand in semiconductor-related markets, especially generative AI.

• Profit attributable to owners of parent for 1Q FY2027 was ¥5,686 million, up 129.5% year-over-year.

• Full-year FY2027 net sales forecast revised upward to ¥193,000 million (+22.2% YoY), with operating and ordinary profit forecast at ¥28,500 million (+45% YoY).

• ROE is expected to improve from 9.4% in FY2026 to 11.9% in FY2027.

• The global economic environment remains uncertain due to geopolitical risks and fluctuating interest and exchange rates.

Financial highlights

• Gross profit increased to ¥15,566 million from ¥10,547 million year-over-year.

• Ordinary income for 1Q FY2027 was ¥8,242 million, up 123% year-over-year.

• Comprehensive income reached ¥10,207 million, up 213% year-over-year.

• Basic earnings per share rose to ¥85.09 from ¥37.09 year-over-year.

• Total assets increased to ¥241,918 million at end of June 2026, up ¥15,197 million from March 2026.

Outlook and guidance

• Upward revision to full-year FY2027 forecast for both revenue and profit, reflecting expansion in semiconductor-related markets.

• FY2027 annual dividend forecast raised to ¥112 per share, up ¥31 year-over-year.

• Profit attributable to owners of parent projected at ¥19,000 million, up 39.9% year-over-year.

• Revenue and profit are tracking above initial forecasts, especially in the Components segment.

• Interim and year-end dividends for FY2027 have not been determined; previous year’s total dividend was ¥81.00 per share.